PMID- 30352986 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20231005 IS - 1999-4923 (Print) IS - 1999-4923 (Electronic) IS - 1999-4923 (Linking) VI - 10 IP - 4 DP - 2018 Oct 24 TI - Silk/Fibroin Microcarriers for Mesenchymal Stem Cell Delivery: Optimization of Cell Seeding by the Design of Experiment. LID - 10.3390/pharmaceutics10040200 [doi] LID - 200 AB - In this methodological paper, lyophilized fibroin-coated alginate microcarriers (LFAMs) proposed as mesenchymal stem cells (MSCs) delivery systems and optimal MSCs seeding conditions for cell adhesion rate and cell arrangement, was defined by a Design of Experiment (DoE) approach. Cells were co-incubated with microcarriers in a bioreactor for different time intervals and conditions: variable stirring speed, dynamic culture intermittent or continuous, and different volumes of cells-LFAMs loaded in the bioreactor. Intermittent dynamic culture resulted as the most determinant parameter; the volume of LFAMs/cells suspension and the speed used for the dynamic culture contributed as well, whereas time was a less influencing parameter. The optimized seeding conditions were: 98 min of incubation time, 12.3 RPM of speed, and 401.5 microL volume of cells-LFAMs suspension cultured with the intermittent dynamic condition. This DoE predicted protocol was then validated on both human Adipose-derived Stem Cells (hASCs) and human Bone Marrow Stem Cells (hBMSCs), revealing a good cell adhesion rate on the surface of the carriers. In conclusion, microcarriers can be used as cell delivery systems at the target site (by injection or arthroscopic technique), to maintain MSCs and their activity at the injured site for regenerative medicine. FAU - Perucca Orfei, Carlotta AU - Perucca Orfei C AD - IRCCS Istituto Ortopedico Galeazzi, Orthopaedic Biotechnology Lab, Via R. Galeazzi 4, 20161 Milano, Italy. carlotta.perucca@grupposandonato.it. FAU - Talo, Giuseppe AU - Talo G AUID- ORCID: 0000-0003-1976-5073 AD - IRCCS Istituto Ortopedico Galeazzi, Cells and Tissue Engineering Laboratory, Via R. Galeazzi 4, 20161 Milano, Italy. giuseppe.talo@grupposandonato.it. FAU - Vigano, Marco AU - Vigano M AUID- ORCID: 0000-0002-6463-6564 AD - IRCCS Istituto Ortopedico Galeazzi, Orthopaedic Biotechnology Lab, Via R. Galeazzi 4, 20161 Milano, Italy. marco.vigano@grupposandonato.it. FAU - Perteghella, Sara AU - Perteghella S AUID- ORCID: 0000-0003-1128-7636 AD - Department of Drug Sciences, University of Pavia, via T. Taramelli 12, 27100 Pavia, Italy. sara.perteghella@unipv.it. FAU - Lugano, Gaia AU - Lugano G AD - IRCCS Istituto Ortopedico Galeazzi, Orthopaedic Biotechnology Lab, Via R. Galeazzi 4, 20161 Milano, Italy. gaia.lugano@grupposandonato.it. FAU - Fabro Fontana, Francesca AU - Fabro Fontana F AD - Department of Drug Sciences, University of Pavia, via T. Taramelli 12, 27100 Pavia, Italy. ffrancesca.fontana@gmail.com. FAU - Ragni, Enrico AU - Ragni E AD - IRCCS Istituto Ortopedico Galeazzi, Orthopaedic Biotechnology Lab, Via R. Galeazzi 4, 20161 Milano, Italy. enrico.ragni@grupposandonato.it. FAU - Colombini, Alessandra AU - Colombini A AUID- ORCID: 0000-0002-1800-3424 AD - IRCCS Istituto Ortopedico Galeazzi, Orthopaedic Biotechnology Lab, Via R. Galeazzi 4, 20161 Milano, Italy. alessandra.colombini@grupposandonato.it. FAU - De Luca, Paola AU - De Luca P AD - IRCCS Istituto Ortopedico Galeazzi, Orthopaedic Biotechnology Lab, Via R. Galeazzi 4, 20161 Milano, Italy. deluca.paola@grupposandonato.it. FAU - Moretti, Matteo AU - Moretti M AD - IRCCS Istituto Ortopedico Galeazzi, Cells and Tissue Engineering Laboratory, Via R. Galeazzi 4, 20161 Milano, Italy. matteo.moretti@grupposandonato.it. FAU - Torre, Maria Luisa AU - Torre ML AUID- ORCID: 0000-0001-8062-6836 AD - Department of Drug Sciences, University of Pavia, via T. Taramelli 12, 27100 Pavia, Italy. marina.torre@unipv.it. FAU - de Girolamo, Laura AU - de Girolamo L AD - IRCCS Istituto Ortopedico Galeazzi, Orthopaedic Biotechnology Lab, Via R. Galeazzi 4, 20161 Milano, Italy. laura.degirolamo@grupposandonato.it. LA - eng GR - 42617604/Regione Lombardia/ PT - Journal Article DEP - 20181024 PL - Switzerland TA - Pharmaceutics JT - Pharmaceutics JID - 101534003 PMC - PMC6321597 OTO - NOTNLM OT - alginate OT - cell delivery OT - design of experiment OT - mesenchymal stem cells OT - microcarrier OT - one-step clinical procedure OT - silk fibroin COIS- The authors declare no conflict of interest. EDAT- 2018/10/26 06:00 MHDA- 2018/10/26 06:01 PMCR- 2018/12/01 CRDT- 2018/10/25 06:00 PHST- 2018/09/10 00:00 [received] PHST- 2018/10/18 00:00 [revised] PHST- 2018/10/22 00:00 [accepted] PHST- 2018/10/25 06:00 [entrez] PHST- 2018/10/26 06:00 [pubmed] PHST- 2018/10/26 06:01 [medline] PHST- 2018/12/01 00:00 [pmc-release] AID - pharmaceutics10040200 [pii] AID - pharmaceutics-10-00200 [pii] AID - 10.3390/pharmaceutics10040200 [doi] PST - epublish SO - Pharmaceutics. 2018 Oct 24;10(4):200. doi: 10.3390/pharmaceutics10040200.